This fact might point towards the utility of PD-L2 methylation testing to determine not only the effective, potentially transient PD-L2 protein expression but also the general ability of melanoma cells to express PD-L2 protein under specific proinflammatory conditions. This evidence concerns the gene PDCD1LG2 and melanoma.